Vertex Pharmaceuticals Inc. buy JPMorgan Chase & Co.
Start price
06.05.25
/
50%
€387.85
Target price
06.05.26
€455.98
Performance (%)
0.40%
Price
23.12.25
€389.40
Summary
This prediction is currently active. The BUY prediction by JPMorgan_Chase___Co_ for Vertex Pharmaceuticals Inc. is nearly unchanged. This prediction currently runs until 06.05.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Vertex Pharmaceuticals Inc. | 2.031% | 2.031% |
| iShares Core DAX® | 0.650% | 3.212% |
| iShares Nasdaq 100 | 1.650% | 0.322% |
| iShares Nikkei 225® | 1.232% | 1.549% |
| iShares S&P 500 | 1.413% | 0.282% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target raised by analysts at JPMorgan Chase & Co. from $512.00 to $515.00. They now have an "overweight" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€361.35
08.10.25
08.10.25
€455.85
08.10.26
08.10.26
7.76%
23.12.25
23.12.25
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€404.90
14.07.25
14.07.25
€442.35
14.07.26
14.07.26
-3.83%
23.12.25
23.12.25
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€379.25
23.12.24
23.12.24
€480.45
23.12.25
23.12.25
2.68%
24.12.25
24.12.25
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€457.60
05.11.24
05.11.24
€460.55
05.11.25
05.11.25
-21.31%
06.11.25
06.11.25
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€432.30
05.08.24
05.08.24
€464.36
05.08.25
05.08.25
-24.98%
06.08.25
06.08.25
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€400.30
01.02.24
01.02.24
€404.41
01.02.25
01.02.25
10.22%
02.02.25
02.02.25